Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : A Real American President: Donald Trump -- Ignore unavailable to you. Want to Upgrade?

To: didjuneau who wrote (375725)	11/20/2022 5:15:16 PM
From: bruwin	2 Recommendations Recommended By Honey_Bee Tom Clarke Respond to of 455776

I can only, once again, refer to the Video by Dr, John Campbell who discusses BOTH IVERMECTIN and PAXLOVID as PROTEASE INHIBITORS and how both go about their business ...... Whenever Dr. Campbell puts out a Video about a Medical Issue he doesn't do it on the basis of him expressing his personal Opinion or Bias. He makes his presentation with REFERENCE to serious Medical Papers on the Subject. He does just that in the above video ...... I suggest one goes to 9:24 and 11:00 in the video where he discusses important aspects. Here is one of the papers he referred to with regard to IVERMECTIN which was presented by the ROYAL SOCIETY OF CHEMISTRY. They are certainly not a collection of "Backyard Hacks" -----> And here is the LINK to the actual Article ------> pubs.rsc.org The thing is ........... if one does a search on the usual collection of Search Engines about both PAXLOVID and IVERMECTIN as PROTEASE INHIBITORS, the collection of "PROPAGANDISTS" within those enclaves will "Inform(?)" you that IVERMECTIN is nowhere near being a PROTEASE INHIBITOR (PI) as is Pfizer's new "Wonder Drug", PAXLOVID. BUT ....... Dr. Campbell shows one that that is COMPLETE BULLSHIT. The fact is that IVERMECTIN is, in effect, a better PI because it can already identify more than ONE Protein that COVID-19 needs to attach itself to a body's cell. At this stage, PAXLOVID can only recognize ONE PROTEIN, which could be an INHIBITIVE Factor in the future if the COVID-19 Virus should mutate, as these types of Viruses tend to do, and then use a PROTEIN that PAXLOVID cannot recognize but IVERMECTIN can.